ciprofloxacin has been researched along with AIDS-Related Opportunistic Infections in 44 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
AIDS-Related Opportunistic Infections: Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "During a randomized study of clarithromycin plus clofazimine with or without ethambutol in patients with AIDS and Mycobacterium avium complex (MAC) bacteremia, eight participants received additional antimycobacterial drugs following the detection of a clarithromycin-resistant isolate (MIC, > 8 micrograms/mL)." | 9.09 | Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. ( Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ, 1999) |
| " avium complex bacteremia to receive either rifampin (600 mg daily), ethambutol (approximately 15 mg per kilogram of body weight daily), clofazimine (100 mg daily), and ciprofloxacin (750 mg twice daily) (the four-drug group) or rifabutin (600 mg daily), ethambutol (as above), and clarithromycin (1000 mg twice daily) (the three-drug group)." | 9.08 | A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. ( Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP, 1996) |
| "During a randomized study of clarithromycin plus clofazimine with or without ethambutol in patients with AIDS and Mycobacterium avium complex (MAC) bacteremia, eight participants received additional antimycobacterial drugs following the detection of a clarithromycin-resistant isolate (MIC, > 8 micrograms/mL)." | 5.09 | Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group. ( Dubé, MP; Havlir, DV; Kemper, CA; Leedom, JM; McCutchan, JA; Sattler, FR; See, D; Tilles, JG; Torriani, FJ, 1999) |
| "To compare 1 week of trimethoprim-sulfamethoxazole treatment and 1 week of ciprofloxacin treatment in HIV-infected patients with chronic diarrhea caused by I." | 5.09 | Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial. ( Fitzgerald, DW; Johnson, WD; Pape, JW; Verdier, RI, 2000) |
| " avium complex bacteremia to receive either rifampin (600 mg daily), ethambutol (approximately 15 mg per kilogram of body weight daily), clofazimine (100 mg daily), and ciprofloxacin (750 mg twice daily) (the four-drug group) or rifabutin (600 mg daily), ethambutol (as above), and clarithromycin (1000 mg twice daily) (the three-drug group)." | 5.08 | A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. ( Fanning, MM; Fong, IW; Gill, MJ; Lalonde, RG; Phillips, P; Rachlis, AR; Salit, I; Shafran, SD; Singer, J; Tsoukas, CM; Walmsley, SL; Zarowny, DP, 1996) |
| "Amikacin was well tolerated." | 2.69 | A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team. ( Barber, TW; Currier, J; Ellner, JJ; Hafner, R; Hojczyk, P; Hooton, TM; Jacobs, MR; Limjoco, M; Parenti, DM; Powderly, WG; Simpson, G; van der Horst, C; Williams, PL, 1998) |
| "ciprofloxacin were as follows: peak concentration of drug in serum (Cmax), 2." | 2.68 | Oral bioavailability and pharmacokinetics of ciprofloxacin in patients with AIDS. ( Banevicius, MA; Nicolau, DP; Nightingale, CH; Owens, RC; Patel, KB; Quintiliani, R, 1997) |
| "cinaedi bacteremia have been published; most cases have presented as a nonspecific febrile illness in homosexual men infected with the human immunodeficiency virus (HIV)." | 2.39 | Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia. ( Burman, WJ; Cohn, DL; Reves, RR; Wilson, ML, 1995) |
| "The skin biopsy was compatible with bacillary angiomatosis." | 1.38 | [Bacillary angiomatosis]. ( Balcells, ME; Cárdenas, C; García, P; Giesen, L; González, S; Uribe, P, 2012) |
| "Peritonitis is a major complication of peritoneal dialysis (PD)." | 1.33 | Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis. ( Jeyaratnam, D; Keenan, N; Sheerin, NS, 2005) |
| " The potent antiinflammatory, antifungal, and anti-HIV-1 activity for a number of previously reported manzamines is also presented in addition to the pharmacokinetic studies of manzamine A (5)." | 1.32 | New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases. ( Charman, WN; Hamann, MT; Hammond, NL; Mayer, AM; McIntosh, KA; Peng, J; Wahyuono, S; Yousaf, M, 2004) |
| "The patient was treated for bacterial meningitis and made a good recovery." | 1.29 | Non-typhoid Salmonella subdural empyema in a patient with AIDS. ( Codeluppi, M; D'Andrea, L; De Rienzo, B; Guaraldi, G; Manicardi, G; Mongiardo, N; Mussini, C; Squadrini, F; Trenti, F, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 28 (63.64) | 18.2507 |
| 2000's | 12 (27.27) | 29.6817 |
| 2010's | 4 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yousaf, M | 1 |
| Hammond, NL | 1 |
| Peng, J | 1 |
| Wahyuono, S | 1 |
| McIntosh, KA | 1 |
| Charman, WN | 1 |
| Mayer, AM | 1 |
| Hamann, MT | 1 |
| Trone, MC | 1 |
| Manoli, P | 1 |
| Mattei, J | 1 |
| Thuret, G | 1 |
| Gain, P | 1 |
| Stephan, JL | 1 |
| Kreft, B | 1 |
| Oehme, A | 1 |
| Lübbert, C | 1 |
| Marsch, WC | 1 |
| Kekulé, AS | 1 |
| Mazumder, SA | 1 |
| Cleveland, KO | 1 |
| Uribe, P | 1 |
| Balcells, ME | 1 |
| Giesen, L | 1 |
| Cárdenas, C | 1 |
| García, P | 1 |
| González, S | 1 |
| Ginsburg, AS | 1 |
| Woolwine, SC | 1 |
| Hooper, N | 1 |
| Benjamin, WH | 1 |
| Bishai, WR | 1 |
| Dorman, SE | 1 |
| Sterling, TR | 1 |
| Desimone, JA | 1 |
| Babinchak, TJ | 1 |
| Kaulback, KR | 1 |
| Pomerantz, RJ | 1 |
| Keenan, N | 1 |
| Jeyaratnam, D | 1 |
| Sheerin, NS | 1 |
| Chidzonga, MM | 1 |
| Espinoza-Gómez, F | 1 |
| Newton-Sánchez, OA | 1 |
| Melnikov, V | 1 |
| Virgen-González, O | 1 |
| Unrau, J | 1 |
| Mussini, C | 1 |
| Trenti, F | 1 |
| Manicardi, G | 1 |
| Mongiardo, N | 1 |
| Codeluppi, M | 1 |
| D'Andrea, L | 1 |
| Guaraldi, G | 1 |
| Squadrini, F | 1 |
| De Rienzo, B | 1 |
| Burman, WJ | 1 |
| Cohn, DL | 1 |
| Reves, RR | 1 |
| Wilson, ML | 1 |
| Lucena, MI | 1 |
| Marquez, M | 1 |
| Velasco, JL | 1 |
| Andrade, RJ | 1 |
| Greten, T | 1 |
| Hautmann, H | 1 |
| Trauner, A | 1 |
| Huber, RM | 1 |
| Steven, N | 1 |
| Pithie, A | 1 |
| Wood, M | 1 |
| Innes, J | 1 |
| Elcuaz, R | 1 |
| Lluch-Perales, JF | 1 |
| Gómez, E | 1 |
| Suárez, J | 1 |
| Hernández, M | 1 |
| LaFarga, B | 1 |
| de la Fuente, J | 1 |
| Albo, C | 1 |
| Rodríguez, A | 1 |
| Sopeña, B | 1 |
| Martínez, C | 1 |
| Gordon, SM | 1 |
| Horsburgh, CR | 1 |
| Peloquin, CA | 1 |
| Havlik, JA | 1 |
| Metchock, B | 1 |
| Heifets, L | 1 |
| McGowan, JE | 1 |
| Thompson, SE | 1 |
| Peterson, MC | 1 |
| Farr, RW | 1 |
| Castiglia, M | 1 |
| Kiehn, TE | 1 |
| White, M | 1 |
| Pursell, KJ | 1 |
| Boone, N | 1 |
| Tsivitis, M | 1 |
| Brown, AE | 1 |
| Polsky, B | 1 |
| Armstrong, D | 1 |
| Clark, JA | 1 |
| Margolis, DM | 1 |
| Jacobson, MA | 1 |
| Yajko, D | 1 |
| Northfelt, D | 1 |
| Charlebois, E | 1 |
| Gary, D | 1 |
| Brosgart, C | 1 |
| Sanders, CA | 1 |
| Hadley, WK | 1 |
| Tee, W | 1 |
| Mijch, A | 1 |
| Wright, E | 1 |
| Yung, A | 1 |
| Shafran, SD | 2 |
| Singer, J | 2 |
| Zarowny, DP | 1 |
| Phillips, P | 1 |
| Salit, I | 2 |
| Walmsley, SL | 1 |
| Fong, IW | 1 |
| Gill, MJ | 1 |
| Rachlis, AR | 1 |
| Lalonde, RG | 1 |
| Fanning, MM | 1 |
| Tsoukas, CM | 2 |
| Sharpstone, D | 1 |
| Gazzard, B | 1 |
| Kennedy, N | 1 |
| Berger, L | 1 |
| Curram, J | 1 |
| Fox, R | 1 |
| Gutmann, J | 1 |
| Kisyombe, GM | 1 |
| Ngowi, FI | 1 |
| Ramsay, AR | 1 |
| Saruni, AO | 1 |
| Sam, N | 1 |
| Tillotson, G | 1 |
| Uiso, LO | 1 |
| Yates, M | 1 |
| Gillespie, SH | 1 |
| Macías, J | 1 |
| Pineda, JA | 1 |
| Borderas, F | 1 |
| Gallardo, JA | 1 |
| Delgado, J | 1 |
| Leal, M | 1 |
| Sánchez-Quijano, A | 1 |
| Lissen, E | 1 |
| Owens, RC | 1 |
| Patel, KB | 1 |
| Banevicius, MA | 1 |
| Quintiliani, R | 1 |
| Nightingale, CH | 1 |
| Nicolau, DP | 1 |
| Nettles, RE | 1 |
| Sexton, DJ | 1 |
| Baraia-Etxaburu, J | 1 |
| Malero, P | 1 |
| Unzaga, MJ | 1 |
| Teira, R | 1 |
| Muñoz, J | 1 |
| Cisterna, R | 1 |
| Santamaría, JM | 1 |
| Butt, AA | 1 |
| Mascellino, MT | 1 |
| Farinelli, S | 1 |
| Iegri, F | 1 |
| Iona, E | 1 |
| Martinelli, F | 1 |
| Caruso, A | 1 |
| Ausenda, S | 1 |
| Corulli, M | 1 |
| Licenziati, S | 1 |
| Garrafa, E | 1 |
| Turano, A | 1 |
| Barzilai, A | 1 |
| Rubinovich, B | 1 |
| Blank-Porat, D | 1 |
| Rubinstein, E | 1 |
| Keller, N | 1 |
| Levi, I | 1 |
| Parenti, DM | 1 |
| Williams, PL | 1 |
| Hafner, R | 1 |
| Jacobs, MR | 1 |
| Hojczyk, P | 1 |
| Hooton, TM | 1 |
| Barber, TW | 1 |
| Simpson, G | 1 |
| van der Horst, C | 1 |
| Currier, J | 1 |
| Powderly, WG | 1 |
| Limjoco, M | 1 |
| Ellner, JJ | 1 |
| Dubé, MP | 1 |
| Torriani, FJ | 1 |
| See, D | 1 |
| Havlir, DV | 1 |
| Kemper, CA | 1 |
| Leedom, JM | 1 |
| Tilles, JG | 1 |
| McCutchan, JA | 1 |
| Sattler, FR | 1 |
| Thorne, A | 1 |
| Khorasheh, S | 1 |
| Raboud, JM | 1 |
| Wu, AW | 1 |
| Lemieux, C | 1 |
| Verdier, RI | 1 |
| Fitzgerald, DW | 1 |
| Johnson, WD | 1 |
| Pape, JW | 1 |
| Bandera, A | 1 |
| Gori, A | 1 |
| Rossi, MC | 1 |
| Degli Esposti, A | 1 |
| Ferrario, G | 1 |
| Marchetti, G | 1 |
| Tocalli, L | 1 |
| Franzetti, F | 1 |
| Hung, CC | 1 |
| Hsieh, SM | 1 |
| Hsiao, CF | 1 |
| Chen, MY | 1 |
| Sheng, WH | 1 |
| Sène, D | 1 |
| Bossi, P | 1 |
| Thomas, L | 1 |
| Ghosn, J | 1 |
| Zeller, V | 1 |
| Caumes, E | 1 |
| Katlama, C | 1 |
| Bricaire, F | 1 |
| Richter, E | 1 |
| Wessling, J | 1 |
| Lügering, N | 1 |
| Domschke, W | 1 |
| Rüsch-Gerdes, S | 1 |
| Nelson, MR | 1 |
| Shanson, DC | 1 |
| Hawkins, DA | 1 |
| Gazzard, BG | 1 |
| Albrecht, H | 1 |
| Stellbrink, HJ | 1 |
| Fenske, S | 1 |
| Steiner, P | 1 |
| Greten, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.[NCT00000641] | Phase 2 | 90 participants | Interventional | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for ciprofloxacin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Rifabutin-associated uveitis in a 10-year-old child with HIV: Case report and review of the literature.
Topics: AIDS-Related Opportunistic Infections; Child; Ciprofloxacin; Drug Substitution; Female; HIV; HIV Inf | 2018 |
Multifocal cellulitis and monoarticular arthritis as manifestations of Helicobacter cinaedi bacteremia.
Topics: Adult; AIDS-Related Opportunistic Infections; Arthritis, Infectious; Bacteremia; Cellulitis; Child, | 1995 |
[Esophagomediastinal fistulae as a rare complication of tuberculosis in an HIV-infected patient].
Topics: AIDS-Related Opportunistic Infections; Ciprofloxacin; Drug Therapy, Combination; Esophageal Fistula; | 1994 |
Gastrointestinal manifestations of HIV infection.
Topics: AIDS-Related Opportunistic Infections; Animals; Cachexia; Ciprofloxacin; Diarrhea; Gastrointestinal | 1996 |
Cervical adenitis due to Mycobacterium fortuitum in patients with acquired immunodeficiency syndrome.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; Drainage; Drug | 1998 |
8 trials available for ciprofloxacin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
Randomized, placebo-controlled trial of rifampin, ethambutol, and ciprofloxacin for AIDS patients with disseminated Mycobacterium avium complex infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Double-Blind Method; Drug Synergism; Dr | 1993 |
A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antitubercular Agents; Bacterem | 1996 |
Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciproflo | 1996 |
Oral bioavailability and pharmacokinetics of ciprofloxacin in patients with AIDS.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Biologica | 1997 |
A phase II/III trial of antimicrobial therapy with or without amikacin in the treatment of disseminated Mycobacterium avium infection in HIV-infected individuals. AIDS Clinical Trials Group Protocol 135 Study Team.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Bacteremia; Ciprofloxacin; Clofazimine; Colo | 1998 |
Successful short-term suppression of clarithromycin-resistant Mycobacterium avium complex bacteremia in AIDS. California Collaborative Treatment Group.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Ciprofloxacin; Clarithromycin; Clofazimine; Drug | 1999 |
Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Bacteremia; Canada; | 2000 |
Trimethoprim-sulfamethoxazole compared with ciprofloxacin for treatment and prophylaxis of Isospora belli and Cyclospora cayetanensis infection in HIV-infected patients. A randomized, controlled trial.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Animals; Anti-Infective Agents; Chronic Di | 2000 |
31 other studies available for ciprofloxacin and AIDS-Related Opportunistic Infections
| Article | Year |
|---|---|
New manzamine alkaloids from an Indo-Pacific sponge. Pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases.
Topics: Administration, Oral; AIDS-Related Opportunistic Infections; Animals; Anti-Bacterial Agents; Anti-HI | 2004 |
[37-year old patient with fever, diarrhea and lymphadenopathy].
Topics: Adult; AIDS Serodiagnosis; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Antifungal | 2010 |
Bordetella bronchiseptica bacteremia in a patient with AIDS.
Topics: Adult; AIDS-Associated Nephropathy; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Ba | 2010 |
[Bacillary angiomatosis].
Topics: Adult; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Anti-Bacterial Agents; Azithr | 2012 |
The rapid development of fluoroquinolone resistance in M. tuberculosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, | 2003 |
Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiretroviral Therapy, Highly | 2003 |
Mycobacterium simiae: a previously undescribed pathogen in peritoneal dialysis peritonitis.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Antiretroviral Therapy, Highly | 2005 |
Necrotizing fasciitis of the cervical region in an AIDS patient: report of a case.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Dental Car | 2005 |
Meningitis caused by Alcaligenes xylosoxidans in a patient with HIV/AIDS.
Topics: AIDS-Related Opportunistic Infections; Alcaligenes; Anti-Infective Agents; Ciprofloxacin; Gram-Negat | 2007 |
Non-typhoid Salmonella subdural empyema in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Brain; Brain Abscess; Cefotaxime; Chloramphenicol; Cip | 1995 |
Acute renal failure attributable to ciprofloxacin in a patient with the acquired immunodeficiency syndrome.
Topics: Acute Kidney Injury; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Humans; Male; Pneu | 1995 |
Corticosteroid therapy for AIDS patients with Mycobacterium avium-intracellulare infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Azithromycin; Ciprofloxacin; Clofazimine; Drug Therapy | 1994 |
[Bacteremia caused by quinolone-resistant Campylobacter jejuni in a patient with HIV infection].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Campylobacter Infec | 1994 |
Bordetella bronchiseptica pneumonia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Bordetella bronchi | 1994 |
Low serum levels of oral antimycobacterial agents in patients with disseminated Mycobacterium avium complex disease.
Topics: Administration, Oral; Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agent | 1993 |
Prosthetic hip infection and bacteremia due to Campylobacter jejuni in a patient with AIDS.
Topics: AIDS-Related Opportunistic Infections; Bacteremia; Campylobacter Infections; Campylobacter jejuni; C | 1993 |
A cluster of four cases of Mycobacterium haemophilum infection.
Topics: Adult; AIDS-Related Opportunistic Infections; Amikacin; Antitubercular Agents; Bone Marrow Transplan | 1993 |
A cutaneous lesion in a patient with AIDS: an unusual presentation of infection due to Mycobacterium avium complex.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromycin; D | 1993 |
Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Campylob | 1995 |
Rhodococcus or mycobacterium? An example of misdiagnosis in HIV infection.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromy | 1997 |
Successful treatment of Edwardsiella tarda prosthetic valve endocarditis in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Ampicillin; Cefotaxime; Ciprofloxacin; Drug Therapy, C | 1997 |
[Pneumonia caused by Rhodococcus equi in patients with AIDS: difficulty in defining the most appropriate initial treatment].
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; Clarithromy | 1997 |
The influence of the SOS response on the activity of 4-quinolones and zidovudine against some strains of Enterobacteria.
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Bacteremia; Ciproflox | 1998 |
Isolation and chemoantibiotic resistance of Ureaplasma urealyticum in HIV-1 infected patients.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; | 1998 |
Successful treatment of disseminated Mycobacterium simiae infection in AIDS patients.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Bacteremia; Ciprofl | 1998 |
A case of costochondral abscess due to Corynebacterium minutissimum in an HIV-infected patient.
Topics: Abscess; Adult; AIDS-Related Opportunistic Infections; Amikacin; Amoxicillin; Anti-Bacterial Agents; | 2000 |
Risk of recurrent non-typhoid Salmonella bacteraemia after early discontinuation of ciprofloxacin as secondary prophylaxis in AIDS patients in the era of highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-Infecti | 2001 |
[Legionellosis in HIV-1 infected patients. 4 case reports].
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Ciproflo | 2002 |
Mycobacterium avium subsp. paratuberculosis infection in a patient with HIV, Germany.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antitubercular Agents; Ciproflo | 2002 |
Salmonella, Campylobacter and Shigella in HIV-seropositive patients.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Campylobacter Infections; CD4-Positive T-Lymphoc | 1992 |
Salmonella typhimurium lung abscesses in an HIV-infected patient: successful treatment with oral ciprofloxacin.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ciprofloxacin; HIV-1; Humans; Lu | 1992 |